NeoGenomics Share Price

NeoGenomics Share Price

NASDAQ: NEO | Small Cap | Industrials
$14.82
-$0.21 (-1.43%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

NeoGenomics Stock Performance

Open
$14.89
Prev. Close
$15.04
Circuit Range
N/A
Day Range
$14.63 - $15.10
Year Range
$7.07 - $20.02
Volume
65,339
Average Traded
$14.82

NeoGenomics Share Price Today

As of 22 November 2026, NeoGenomics, Inc.'s share price is $14.82. The stock opened at $14.89, compared to its previous close of $15.04. During today's trading session, NeoGenomics, Inc.'s share price traded between $14.63 and $15.10, with an average price of $14.86. Over the past 52 weeks, the stock has recorded a high of $20.02 and a low of $7.07. In terms of performance, NeoGenomics, Inc.'s share price has risen by 40.87% over the last six months and is up 22.38% on a year-on-year basis.

NeoGenomics Share Price Chart

Line chart of the NeoGenomics price trend over the selected period. The price fell overall, ranging from 14.63 to 15.10, ending at 14.82.
$14.63$15.10
L
Show Current Price
H

NeoGenomics Stock Fundamentals & Key Indicators

Market Cap
$1.90B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.25
Revenue (TTM)
$727.33B
Return On Equity (TTM)
-4.03%
Profit Margin
-14.85%
Debt to Equity
0.48
Quarterly Earnings Growth YoY
23.58%

NeoGenomics Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$190.17$186.67$201.66$209.25
Net Profit-$9.88-$17.11$2.24-$7.55
Net Profit Margin-5.20%-9.17%1.11%-3.61%
Income ChangeN/A-73.18%113.09%-437.05%

NeoGenomics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$509.73$591.64$660.57$727.33
Net Profit-$144.25-$87.97-$78.73-$108.03
Net Profit Margin-28.30%-14.87%-11.92%-14.85%
Income ChangeN/A39.02%10.50%-37.22%

NeoGenomics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets983.541042.021084.421134.74
Current Assets376.29596.02596.81605.29
Total Assets1359.831638.041681.231740.03
Non Current Liabilities434.97434.46643.39652.08
Current Liabilities88.3301.2496.389.93
Total Liabilities523.27735.7739.69742.01
Shareholders' Equity836.56902.34941.54998.02

NeoGenomics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating5.237.02-1.95-65.99
Investing-12.3412.8676.710.52
Financing-200.294.654.5511.83

About NeoGenomics

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

NeoGenomics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$17.49
$14.79
-14.83%
Oct 2026
$18.11
$17.36
-5.50%
Sep 2026
$17.76
$18.37
-1.47%
Aug 2026
$15.60
$18.64
+21.98%
Jul 2026
$14.60
$15.29
+4.80%
Jun 2026
$10.60
$14.59
+38.64%
May 2026
$9.41
$10.52
+13.55%
Apr 2026
$7.53
$9.27
+25.03%
Mar 2026
$9.72
$7.41
-24.54%
Feb 2026
$12.10
$9.82
-18.64%
Jan 2026
$11.79
$12.07
+2.72%
Dec 2025
$11.92
$11.75
-2.97%

NeoGenomics Share Price FAQs